News & Perspective

Nov 30, 2001

Nov 30, 2001

Acambis wins new contract to supply 155 million doses of smallpox vaccine

Nov 29, 2001 (CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded Acambis Inc. a $428 million contract to produce an additional 155 million doses of smallpox vaccine by the end of 2002, HHS Secretary Tommy G. Thompson announced Wednesday.

Jan 28, 2002

Jan 28, 2002

HHS to release $200 million in bioterrorism preparedness funds to states

(CIDRAP News) – The US Department of Health and Human Services (HHS) will soon release about 20% of the $1 billion in bioterrorism preparedness funding that is slated to go to states this year, HHS Secretary Tommy G. Thompson announced Jan 25.

Jan 30, 2002

Jan 30, 2002

State health emergency laws aren't ready for bioterrorism, says expert

(CIDRAP News) – In view of the specter of bioterrorism, it's time to overhaul the hodgepodge of outdated, little-known, inconsistent state laws dealing with public health emergencies in the United States, an expert on the subject told a conference audience in Minneapolis yesterday.

Feb 06, 2002

Feb 06, 2002

Proposed 2003 HHS budget includes a 45% boost in bioterrorism-related spending

(CIDRAP News) – The proposed 2003 budget for the US Department of Health and Human Services (HHS) features a 45% increase in spending for bioterrorism preparedness, with research at the National Institutes of Health (NIH) accounting for much of the increase.

Mar 29, 2002

Mar 29, 2002

Aventis to give millions of smallpox vaccine doses to US government

Aventis Pasteur announced today that it will give an estimated 75 million to 90 million doses of decades-old smallpox vaccine to the US government.

May 24, 2002

May 24, 2002

Congress approves wide-ranging bioterrorism preparedness bill

(CIDRAP News) – The US House and Senate this week approved legislation providing for a wide range of bioterrorism preparedness measures, from funds for hospital preparedness to tracking of dangerous pathogens and increased inspections of imported food.

May 30, 2002

May 30, 2002

Food supply's vulnerability to attack deserves more discussion, Osterholm says

(CIDRAP News) – The United States' food supply makes an attractive target for terrorists, and people in the food industry need to talk more frankly about the risks, bioterrorism expert Michael T. Osterholm, PhD, MPH, said in a Minneapolis speech yesterday.

Sep 05, 2002

Sep 05, 2002

Acambis reports successful phase I trial of cell-culture-grown smallpox vaccine

(CIDRAP News) Ð The smallpox vaccine being produced by Acambis plc for the US government as part of the nation's bioterrorism preparedness program worked well in a Phase I trial, Acambis officials announced this week.

The vaccine, called ACAM1000, generated a characteristic skin lesion or "take" in all those vaccinated, and there were no serious or unusual side effects, the company reported in a Sep 3 news release.

Nov 05, 2002

Nov 05, 2002

FDA licenses repackaged smallpox vaccine from federal stockpile

(CIDRAP News) – The Food and Drug Administration (FDA) has updated the licensing for the government's decades-old stockpile of Dryvax smallpox vaccine by approving a new vaccine kit that includes a new diluent and bifurcated needles, according to federal officials.

Nov 18, 2002

Nov 18, 2002

Decision on smallpox vaccinations expected soon, Osterholm says

(CIDRAP News) – Now that the federal government has some licensed smallpox vaccine in its stockpile, a presidential announcement on vaccination recommendations may be coming very soon, bioterrorism expert Michael T. Osterholm, PhD, MPH, predicted last week.

"I believe that in the next days you'll be hearing from the president about this vaccine," Osterholm told healthcare workers at a meeting in Minneapolis.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»